Sa1883 ADALIMUMAB DRUG LEVELS AT SECONDARY LOSS OF RESPONSE IN CROHN'S DISEASE; ARE WE AIMING HIGH ENOUGH? A RETROSPECTIVE, INTERNATIONAL MULTI-CENTRE STUDY

Authors :: Miles P. Sparrow
Adrian P. Swaine
Rebecca Reynolds
David J. Gibson
Mark G. Ward
Catherine Martin
Xavier Roblin
Peter M. Irving
Source :: Gastroenterology. 158:S-464
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: medicine.medical_specialty
Crohn's disease
Hepatology
business.industry
Secondary loss
Gastroenterology
medicine.disease
Drug levels
Internal medicine
medicine
Adalimumab
Multi centre
business
medicine.drug

Full Text Access

Tools